Skip to main content
Caplight Logo









TissueForm, Inc.

TissueForm, Inc.

Private
Boulder, ColoradoHealthcare & Life Scienceshttps://www.tissueforminc.com/

Last Round

Grant

May 18, 2023

Est. Valuation

$9.75M

Total Funding Raised

$2.37M

Company Overview

TissueForm, Inc. is a biomedical technology company that develops natural implants to restore lost tissue structure.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Advanced Materials, 3D Printing

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

implantable biomaterialsregenerative medicinetissue repairtissue engineeringextracellular matrixECMdermal fillercartilage repairacellular platformtissue scaffoldbio-ink3D bioprintingallograftplastic surgeryorthopedicsmedical implantsSmall Business Innovation ResearchSBIR

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TissueForm, Inc. Comparables

Compare TissueForm, Inc. with similar companies based on industry and business-model similarity.

TissueForm, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ECM Therapeutics, Inc.
81%
Regenative Labs
78%
MTF Biologics
75%

TissueForm, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 18, 2023
SeedJan 1, 2023
GrantMar 23, 2021
GrantMar 22, 2019
GrantNov 20, 2018

Key People

Founding team and executive leadership

Corey Neu

Co-Founder CEO

Founding Team

TissueForm, Inc. Investors

Notable investors and investment history

TissueForm, Inc. investors
InvestorRounds
United States Department of DefenseGrant
Venture Partners at CU BoulderGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 18, 2023

    Secured $250K in grant funding.

  • Jan 1, 2023

    $750K round completed.

TissueForm, Inc. Filings

Explore SEC and related filing metadata, where available.

TissueForm, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about TissueForm, Inc.'s valuation, stock price, and market status.

Is TissueForm, Inc. a public or private company?

TissueForm, Inc. is a private company.

What is the current stock price of TissueForm, Inc.?

TissueForm, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is TissueForm, Inc. worth (valuation)?

Valuation information for TissueForm, Inc. is not publicly available.

Can I buy TissueForm, Inc. stock?

TissueForm, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was TissueForm, Inc.'s last funding round?

Funding round information for TissueForm, Inc. is not publicly available.

Who are the main investors in TissueForm, Inc.?

Investor information for TissueForm, Inc. is not publicly disclosed.

Will TissueForm, Inc. IPO soon?

No public IPO plans have been announced for TissueForm, Inc..

How can I track TissueForm, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor TissueForm, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBoulder, Colorado
Employee Range11
Year Founded2019
Last FundingMay 18, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?